UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045380
Receipt number R000051820
Scientific Title Impact of Cardiac Rehabilitation on Cardiorespiratory parameters: Towards establishment of CR intervention at Queen Elizabeth Central Hospital
Date of disclosure of the study information 2021/09/05
Last modified on 2023/03/08 17:24:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of Cardiac Rehabilitation on Cardiorespiratory parameters: Towards establishment of CR intervention at Queen Elizabeth Central Hospital

Acronym

Impact of Cardiac Rehabilitation on Cardiorespiratory parameters: Towards establishment of CR intervention at Queen Elizabeth Central Hospital

Scientific Title

Impact of Cardiac Rehabilitation on Cardiorespiratory parameters: Towards establishment of CR intervention at Queen Elizabeth Central Hospital

Scientific Title:Acronym

Impact of Cardiac Rehabilitation on Cardiorespiratory parameters: Towards establishment of CR intervention at Queen Elizabeth Central Hospital

Region

Africa


Condition

Condition

Congestive Heart Failure

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The overall aim of this study is to carry out a pilot study to determine the impact of cardiovascular rehabilitation (CR) among patients with a diagnosis of Congestive Heart Failure (CHF). The specific objectives are as follows;

1. To describe the improvements in cardiovascular function among patients with CHF following administration of CR
2. To describe the frequency of hospitalization among patients diagnosed with CHF
3. To describe the challenges that may be associated with establishment of a CR program at QECH

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The cardiorespiratory parameters ie. blood pressure, pulse rate, respiratory rate and oxygen saturation, including exercise tolerance capacity for patients are measured at baseline and after 8, 12, 16 and 24 weeks of receiving CR; the measurements are recorded in a data collection form. All health care workers are provided with questionnaires to input challenges encountered during care delivery, and suggest possible solutions. It is hypothesized that;

1. Patients with CHF would have improved cardiac function
2. Patients with CHF would have increased exercise tolerance capacity
3. Cardiac rehabilitation will be established in a more sustainable way at QECH

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom Maneuver
Other

Interventions/Control_1

Cardiac rehabilitation intervention is to be delivered; constituting prescribed exercise therapy, education and counseling therapies, and monitoring of their well-being and adherence to the secondary prevention medications they are put on by their cardiologists. This intervention will only be given to the treatment arm, and is delivered twice a week at the hospital with one day at home under the supervision of a trained guardian, for a period of 12 weeks. Patients' guardians are to be trained to facilitate and supervise the individualized home exercise program at the beginning of therapy sessions in this study.
The exercise therapy is to be prescribed using 40-70% Heart Rate Reserve for cardiovascular training in relation to patients' Rating of Perceived Exertion (RPE), and exercise monitoring will be done using RPE. Strength training will be prescribed using 30-70% of 1 Repetition Maximum (1RM), 2-4 sets and 10-15 repetitions. Patients in treatment arm will exercise for 55 minutes on each day (15 minutes warm up, 30 minutes conditioning and 10 minutes cool down) using a circuit training. aerobic exercises using treadmill, static bike, stepping box and light ball throwing will be employed. Strength training will employ use of sand bags, therabands and weight bearing exercises on a stepping box.
The education and counseling therapy sessions will be for 15 minutes on each day at the hospital.

Interventions/Control_2

The control arm will only receive short education and counseling therapies at baseline, and after 8, 12, 16 and 24 weeks when they come to the hospital for subsequent assessments and data collection for comparisons.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Men and women aged 18 years and above with a diagnosis of CHF at discharge from hospital, confirmed with an echocardiogram, and attending chest clinic at the QECH

2. On optimized secondary prevention medications

3. Being residents of Blantyre City and its immediate surrounding areas

4. Willing to provide written informed consent and willing to return for follow up

5. Being able to participate in physical activity for cardiac rehabilitation

Key exclusion criteria

1. Failure to provide informed consent

2. Not willing to return for follow up visits

3. Physical impairment that would affect participation in physical activity

4. Patients classified as high risk for cardiac events during exertion

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Alice
Middle name Dwight
Last name Namanja

Organization

Kamuzu University of Health Sciences

Division name

Physiotherapy Department

Zip code

0000

Address

Kamuzu University of Health Sciences, Mahatma Ghandi Road, Private Bag 360, Blantyre 3. Malawi

TEL

+265997759408

Email

anamanja@medcol.mw


Public contact

Name of contact person

1st name Alice
Middle name Dwight
Last name Namanja

Organization

Kamuzu University of Health Sciences

Division name

Physiotherapy Department

Zip code

0000

Address

Kamuzu University of Health Sciences, Mahatma Ghandi Road, Private Bag 360, Blantyre 3. Malawi

TEL

+265997759408

Homepage URL


Email

anamanja@medcol.mw


Sponsor or person

Institute

Kamuzu University of Health Sciences








Institute

Department

Personal name



Funding Source

Organization

The Malawi NCD-BRITE Consortium Grant



The Malawi NCD-BRITE Consortium Grant


Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

Malawi


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The College of Medicine Research and Ethics Committee (COMREC)

Address

P/Bag 360, Blantyre 3. Malawi

Tel

+2651810911

Email

comrec@medcol.mw


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

The Kamuzu University of Health Sciences (Blantyre)


Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 03 Month 10 Day

Date of IRB

2021 Year 03 Month 17 Day

Anticipated trial start date

2021 Year 09 Month 13 Day

Last follow-up date

2022 Year 05 Month 24 Day

Date of closure to data entry

2023 Year 02 Month 13 Day

Date trial data considered complete

2023 Year 02 Month 16 Day

Date analysis concluded

2023 Year 07 Month 30 Day


Other

Other related information



Management information

Registered date

2021 Year 09 Month 05 Day

Last modified on

2023 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051820


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name